397 related articles for article (PubMed ID: 25192236)
41. [Clinical and genetic analysis for two children with congenital disturbance of glycosylation with PMM2 gene mutations].
Ren C; Fang F; Huang Y; Cheng H; Dai L
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):938-42. PubMed ID: 26887550
[TBL] [Abstract][Full Text] [Related]
42. A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report.
Lebredonchel E; Riquet A; Neut D; Broly F; Matthijs G; Klein A; Foulquier F
Ital J Pediatr; 2022 Oct; 48(1):178. PubMed ID: 36221102
[TBL] [Abstract][Full Text] [Related]
43. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals.
Pascoal C; Ferreira I; Teixeira C; Almeida E; Slade A; Brasil S; Francisco R; Ligezka AN; Morava E; Plotkin H; Jaeken J; Videira PA; Barros L; Dos Reis Ferreira V
Orphanet J Rare Dis; 2022 Oct; 17(1):398. PubMed ID: 36309700
[TBL] [Abstract][Full Text] [Related]
44. Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management.
Wicker C; Roux CJ; Goujon L; de Feraudy Y; Hully M; Brassier A; Bérat CM; Chemaly N; Wiedemann A; Damaj L; Abi-Warde MT; Dobbelaere D; Roubertie A; Cano A; Arion A; Kaminska A; Da Costa S; Bruneel A; Vuillaumier-Barrot S; Boddaert N; Pascreau T; Borgel D; Kossorotoff M; Harroche A; de Lonlay P
Mol Genet Metab; 2023 Nov; 140(3):107674. PubMed ID: 37542768
[TBL] [Abstract][Full Text] [Related]
45. Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements.
Coorg R; Lotze TE
Neurology; 2012 Oct; 79(15):e131-3. PubMed ID: 23045520
[No Abstract] [Full Text] [Related]
46. Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?
Čechová A; Honzík T; Edmondson AC; Ficicioglu C; Serrano M; Barone R; De Lonlay P; Schiff M; Witters P; Lam C; Patterson M; Janssen MCH; Correia J; Quelhas D; Sykut-Cegielska J; Plotkin H; Morava E; Sarafoglou K
Mol Genet Metab; 2021 Aug; 133(4):397-399. PubMed ID: 34140212
[TBL] [Abstract][Full Text] [Related]
47. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency.
Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R
Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764
[TBL] [Abstract][Full Text] [Related]
48. Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway.
López-Gálvez R; de la Morena-Barrio ME; López-Lera A; Pathak M; Miñano A; Serrano M; Borgel D; Roldán V; Vicente V; Emsley J; Corral J
Orphanet J Rare Dis; 2020 Oct; 15(1):280. PubMed ID: 33036649
[TBL] [Abstract][Full Text] [Related]
49. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
[TBL] [Abstract][Full Text] [Related]
50. Three families with mild PMM2-CDG and normal cognitive development.
Vals MA; Morava E; Teeäär K; Zordania R; Pajusalu S; Lefeber DJ; Õunap K
Am J Med Genet A; 2017 Jun; 173(6):1620-1624. PubMed ID: 28425223
[TBL] [Abstract][Full Text] [Related]
51. Hyperinsulinaemic hypoglycaemia--leading symptom in a patient with congenital disorder of glycosylation Ia (phosphomannomutase deficiency).
Böhles H; Sewell AA; Gebhardt B; Reinecke-Lüthge A; Klöppel G; Marquardt T
J Inherit Metab Dis; 2001 Dec; 24(8):858-62. PubMed ID: 11916319
[TBL] [Abstract][Full Text] [Related]
52. Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency.
Vurallı D; Yıldız Y; Ozon A; Dursun A; Gönç N; Tokatlı A; Sivri HS; Alikaşifoğlu A
J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):275-286. PubMed ID: 35308014
[TBL] [Abstract][Full Text] [Related]
53. D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial.
Witters P; Andersson H; Jaeken J; Tseng L; van Karnebeek CDM; Lefeber DJ; Cassiman D; Morava E
Orphanet J Rare Dis; 2021 Mar; 16(1):138. PubMed ID: 33743737
[TBL] [Abstract][Full Text] [Related]
54. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).
Barone R; Sturiale L; Fiumara A; Uziel G; Garozzo D; Jaeken J
J Inherit Metab Dis; 2007 Feb; 30(1):107. PubMed ID: 17186415
[TBL] [Abstract][Full Text] [Related]
55. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
[TBL] [Abstract][Full Text] [Related]
56. Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies.
Parrado A; Rubio G; Serrano M; De la Morena-Barrio ME; Ibáñez-Micó S; Ruiz-Lafuente N; Schwartz-Albiez R; Esteve-Solé A; Alsina L; Corral J; Hernández-Caselles T
Glycobiology; 2022 Mar; 32(2):84-100. PubMed ID: 34420056
[TBL] [Abstract][Full Text] [Related]
57. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).
Grünewald S
Biochim Biophys Acta; 2009 Sep; 1792(9):827-34. PubMed ID: 19272306
[TBL] [Abstract][Full Text] [Related]
58. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.
Barone R; Carrozzi M; Parini R; Battini R; Martinelli D; Elia M; Spada M; Lilliu F; Ciana G; Burlina A; Leuzzi V; Leoni M; Sturiale L; Matthijs G; Jaeken J; Di Rocco M; Garozzo D; Fiumara A
J Neurol; 2015 Jan; 262(1):154-64. PubMed ID: 25355454
[TBL] [Abstract][Full Text] [Related]
59. Congenital disorders of glycosylation with neonatal presentation.
Resende C; Carvalho C; Alegria A; Oliveira D; Quelhas D; Bandeira A; Proença E
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24739649
[TBL] [Abstract][Full Text] [Related]
60. Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study.
Witters P; Edmondson AC; Lam C; Johnsen C; Patterson MC; Raymond KM; He M; Freeze HH; Morava E
Orphanet J Rare Dis; 2021 Feb; 16(1):102. PubMed ID: 33632285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
